DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 6Dr. Reddy's Laboratories
02 1Olpha
03 3NanoAlvand
04 2Aizant Drug Research Solutions Pvt. Ltd.
05 2Aurobindo Pharma Limited
06 3Bluepharma
07 3Cipla Medpro South Africa
08 3MSN Laboratories
09 1NANO DARU
10 3Pfizer Consumer Healthcare
11 21Pfizer Inc
12 3Pharmascience Inc.
13 3Pluviaendo
14 3Sun Pharmaceutical Industries Limited
15 3Synthon Pharmaceuticals
16 3Taro Pharmaceutical Industries
17 3Tecnimede
18 1TherDose Pharma
19 3XYZ Pharma
Reset all filters
01 6CAP
02 3CAPSULE; ORAL
03 13CAPSULE;ORAL
04 3Caps
05 10Capsule
06 3Capsule, hard
07 3Filmtabl
08 3Hard Capsules
09 3Hard Gelatin Capsule
10 3Oral Solid Dosage Form
11 9TABLET
12 6TABLET;ORAL
13 1Tablet
14 1Tablets
15 3Blank
Reset all filters
01 3DISCN
02 1Dossier Readiness: Q3 2025
03 3Generic
04 3Lead Market Dossiers- Filed
05 3Lead Market Dossiers- Tentative\nApproved in US
06 3Originator
07 9Prescription
08 6RX
09 39Blank
Reset all filters
01 3Cybrin
02 9IBRANCE
03 12Ibrance
04 16PALBOCICLIB
05 3PMS-PALBOCICLIB
06 1Palbociclib 100 mg Cipla
07 1Palbociclib 125 mg Cipla
08 1Palbociclib 75 mg Cipla
09 1Palbociclib Pfizer 100 mg
10 1Palbociclib Pfizer 125 mg
11 1Palbociclib Pfizer 75 mg
12 3TARO-PALBOCICLIB
13 18Blank
Reset all filters
01 3Australia
02 9Canada
03 7India
04 4Iran
05 1Latvia
06 3Norway
07 6Portugal
08 6South Africa
09 6Switzerland
10 3Turkey
11 22USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA